A new credit facility gives the life science real estate company greater access to capital, while its shares remain under pressure and valuation concerns continue to shape investor sentiment
New York, 8 October 2026 – Alexandria Real Estate Equities is taking steps to strengthen its financial position as its stock price remains under pressure. The life science-focused real estate investment trust has completed an overhaul of its main lending arrangements, including a new $5 billion unsecured revolving credit facility. The agreement also extends potential debt maturities as far as 2032, giving the company more room to manage its finances over the coming years.
The move is important because access to capital is a major part of running a large real estate portfolio. A larger revolving facility gives Alexandria more flexibility to fund operations, manage upcoming obligations, and respond to changing conditions without relying entirely on property sales or other financing sources.
However, the stronger credit position comes against a difficult backdrop for the company’s shares. According to Simply Wall St, Alexandria’s stock was trading at $45.92 when the analysis was published on October 7. The shares had declined 12.78 percent over the previous 30 days and were down 6.23 percent year to date. The one-year total shareholder return had fallen 37.66 percent.
This decline has also created an interesting valuation discussion. Simply Wall St’s most-followed valuation scenario placed the company’s fair value at $52.57, compared with the $45.92 share price at the time. That suggests the stock could be around 12.7 percent below the estimated fair value if the company is able to execute its recovery plans successfully.
Alexandria is not a conventional property company. It specializes in life science real estate and operates properties designed for biotechnology, pharmaceutical, medical research, and advanced technology companies. As of June 30, 2026, the company reported 36 million square feet of operating properties and another 2.8 million square feet of Class A and Class A+ properties under construction.
The company is also working on a planned $2.9 billion capital recycling program and efforts to reduce leverage. These initiatives could improve its financial position, although execution remains important. The company is facing challenges including occupancy pressure, property impairments, and higher leasing costs. Simply Wall St reported portfolio occupancy of 86.9 percent in its latest analysis.
For Alexandria, the new credit agreement therefore represents more than an increase in borrowing capacity. It provides additional financial flexibility while management works through a period of portfolio adjustments and changing conditions in the life science property market.
The next phase will depend on how effectively Alexandria converts this financial flexibility into stronger operations, improved occupancy, disciplined capital management, and sustainable long-term value. For investors watching the life science REIT sector, the company remains a notable example of how real estate businesses are balancing growth ambitions with balance sheet management.
